Product Description
| Cat Number | HY-B1455S1 |
|---|---|
| Category | Isotope-Labeled Compounds |
| Pack Size | 1 EA |
| Description | Clindamycin- 13 C,d 3 is the 13 C- and deuterium labeled Clindamycin. Clindamycin is an orally active and broad-spectrum bacteriostatic lincosamide antibiotic. Clindamycin can inhibit bacterial protein synthesis, possessing the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla). Clindamycin also can be used for researching malaria[1][2][3]. |
| Molecular Weight | 428.99 |
| Research Field | Infection |
| Purity | 99.0 |
| Formula | C17 13CH30D3ClN2O5S |
| Smiles | O=C([C@@H]1C[C@H](CN1[13C]([2H])([2H])[2H])CCC)N[C@@H]([C@@]2([H])O[C@@H]([C@@H]([C@H]([C@H]2O)O)O)SC)[C@@H](Cl)C |
| Scientific Background | Anti-infection;Others |
| Storage | -20°C, 3 years (Powder) |
| View Document | |
| Note | The product is for research use only |
Share Item: